When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

Discover why male breast cancer cases are rising, learn essential warning signs most men miss, and understand new treatment options that could save lives.

Menopausal patients are most interested in learning more about non-hormonal treatments to address their symptoms, according to the results of an international survey led by the Menopause Priority ...

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

Cell cycle re-entry of senescent breast cancer cells after CDK4/6 inhibition (CDK4/6i) constitutes a major source of disease ...

Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.

Hormone therapy uses medication to lower or block ... These systems use nanoparticles to more effectively deliver cancer drugs. Some examples of cancer drugs that may use a nanoparticle-based ...

Drug in Clinical Trials for Breast Cancer ... Dec. 3, 2024 — Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women ...

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.

Breast cancers at all stages are defined by the structure of their genomes, Stanford Medicine researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.